Sientra Revenue and Competitors
Estimated Revenue & Valuation
- Sientra's estimated annual revenue is currently $92.2M per year.
- Sientra's estimated revenue per employee is $402,489
- Sientra's total funding is $321.5M.
- Sientra's current valuation is $176.1M. (January 2022)
Employee Data
- Sientra has 229 Employees.
- Sientra grew their employee count by -3% last year.
Sientra's People
Name | Title | Email/Phone |
---|---|---|
1 | President andCEO | Reveal Email/Phone |
2 | Chief Legal, Compliance, & Corporate Development Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | SVP Sales | Reveal Email/Phone |
5 | VP Reconstruction & Corporate Contracts | Reveal Email/Phone |
6 | SVP, Corporate Strategy and Marketing | Reveal Email/Phone |
7 | GM and SVP Global Sales, Breast Products and miraDry segments | Reveal Email/Phone |
8 | Senior Director, Medical Affairs & Professional Education | Reveal Email/Phone |
9 | Executive Director Quality Assurance | Reveal Email/Phone |
10 | Executive Director, Regulatory and Clinical Affairs | Reveal Email/Phone |
Sientra Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.9M | 34 | N/A | N/A | N/A |
#2 | N/A | 13386 | -6% | N/A | N/A |
#3 | $300M | 658 | N/A | N/A | N/A |
What Is Sientra?
The Sientra Choice. A remarkable difference you can see and feel. It takes a skilled plastic surgeon to create the perfect look. But only your implant can create the right feel. At Sientra, we understand dedication. That's why we cater exclusively to board-certified plastic surgeons. As you deliver on the high expectations of your patients each day, we'll be doing the same for you with innovative products and unsurpassed service. At Sientra, we offer both round and shaped (teardrop) implant options. Each utilizes a proprietary gel fill technology, High-Strength Cohesive (HSC) Silicone Gel, with a formulation unique to each implant shape. HSC round implants are the right choice for a fuller appearance and more dramatic cleavage. Our HSC+ shaped implants, with a more cohesive gel fill, are designed to create a more contoured, natural silhouette. Each style combines our exclusive HSC Silicone Gel interior with a durable outer shell to create a soft, natural-like feel without sacrificing the integrity of the implant. One shape does not fit all. That?s why both HSC round and HSC+ shaped implants are available in different shapes and sizes so that you and your board-certified plastic surgeon can create the look that?s right for you. The gel used as the implant filler material in Sientra?s HSC and HSC+ implants have undergone thorough testing. In rigorous laboratory tests that push breast implants to their limits, Sientra's two gels were demonstrated to be the strongest available on the market, while the complete implants (gel and shell together) remain remarkably soft to the touch. At Sientra, we believe that shared expertise and values are essential components of success. Our leadership is driven by decades of experience and skill that help bring your goals and aesthetic visions to life. See full risk information here: http://bit.ly/2sPVJSL
keywords:Healthcare$321.5M
Total Funding
229
Number of Employees
$92.2M
Revenue (est)
-3%
Employee Growth %
$176.1M
Valuation
N/A
Accelerator
Sientra News
Alpha Pro Tech (NYSE:APT) & Sientra (NASDAQ:SIEN) Critical Review. Posted by admin on Apr 24th, 2022. Share on Twitter Share on Facebook Share on LinkedIn...
Colliers Securities reissued a buy rating on shares of Sientra in a research report on Tuesday, March 22nd. Canaccord Genuity Group dropped...
Shares of Sientra, Inc. (NASDAQ:SIEN Get Rating) have been assigned a consensus recommendation of Buy from the nine analysts that are...
Breast implant maker Sientra (NSDQ:SIEN) said today that the proceeds from its initial public offering, which closed yesterday, put $80.2 million into its coffers. Sientra floated 5.75 million shares at $15 apiece for total proceeds of nearly $86.3 million, plus an over-allotment of 750,000 sha ...
Sientra, Inc. (NASDAQ: SIEN), a Santa Barbara-based medical aesthetics company, raised $75m for its Initial Public Offering after pricing its 5 million shares at $15 per share. The stock began trading Wednesday 29th on the NASDAQ under the ticker symbol SIEN and the offering is expected to clos ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $36.8M | 231 | -2% | N/A |
#2 | $68.9M | 232 | 13% | N/A |
#3 | $73.7M | 254 | 2% | $183M |
#4 | $42.9M | 269 | N/A | N/A |
#5 | $64M | 277 | 5% | N/A |